Amblyopia Market Size, Share, Industry & Opportunities 2030
Global Amblyopia Market
Segments - By Treatments (Atropine Drops, Eye Patches, Glasses, Video Game, and Others), By End-users (Ophthalmic Clinics, Hospitals & Pharmacies and Others), By Diagnosis (Visual Acuity Tests, Photo Screening, Brückner Test, and Others), By Types (Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Reverse Amblyopia, and Others) and By Regions (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
Segments - By Treatments (Atropine Drops, Eye Patches, Glasses, Video Game, and Others), By End-users (Ophthalmic Clinics, Hospitals & Pharmacies and Others), By Diagnosis (Visual Acuity Tests, Photo Screening, Brückner Test, and Others), By Types (Strabismus Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Reverse Amblyopia, and Others) and By Regions (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
The global amblyopia market was valued at USD 4,608.2 Million in 2019 and is projected to reach US$ 6,203.6 Million by 2027, expanding at a CAGR of 4.0% during the forecast period. Amblyopia occurs in early childhood when the brain favors only one of the eye due to improper stimulation between the brain and an eye nerve pathway.
Market Dynamics
The market is driven by factors such as increasing cases of ophthalmological disorders including refractive errors and cataracts across the globe. Moreover, favorable government funding for ophthalmology research is boosting market growth in developing countries such as India, Mexico, and China. Increasing demand for glasses and eye patches at economic costs is fueling growth of the global amblyopia market. Rising treatments pertaining to amblyopia has now extended beyond patching for youngsters and adults to help patients of any ages to get rid of diseases in the present scenario. Thus, consumers are now encouraged to avail for amblyopia treatments around the world.
Modern techniques including the introduction of electronic eyeglasses and lenses are considered as efficient medications of the treatment of amblyopia. These types of modern techniques increase consumer awareness and encourage them to adopt eyeglass, which can be used as part of fashion in correspondence with treatment.
Lack of awareness pertaining to amblyopia treatment and lack of strict government regulation regarding new treatment methods in developing regions challenges the growth of the amblyopia market. Lack of technological advancement and availability of resources restricts the growth of the market globally.
Segmental Outlook
On the basis of treatment, the Global Amblyopia Market has been segmented into eye patches, atropine drops, glasses, video game, and others. The video game treatment segment is anticipated to expand at a CAGR of around 4.1% during the forecast period due to increasing awareness and technological advancements pertaining to the treatment. The eye patches segment is estimated to hold 35.9% share of the market in 2019, as it is a highly preferred treatment for amblyopia in hospitals and various eye care centers.
Based on end-users, the market has been divided into hospitals & pharmacies, ophthalmic clinics, and others. The hospitals & pharmacies segment is projected to hold a dominant share of the market during the forecast period due to easy availability of treatment facilities. Additionally, near ability and awareness about hospitals and pharmacies among end-users support significant share in the market, globally.
The ophthalmic clinics segment is expected to grow at a substantial pace owing to the growing awareness regarding these centers among consumers. Moreover, increasing company focus on opening of new ophthalmic clinics is propelling the growth in the global amblyopia market. New and emerging players are focusing on this segment to withstand the competition in the global amblyopia market.
In terms of diagnosis, the global amblyopia market has been segregated into visual acuity tests, photo screening, Brücknertest, and others. The visual acuity tests segment account for a major share in the global amblyopia market, as it is a basic and mandatory test required before the amblyopia treatment. Increasing research & development and continuous improvements in the Brückner test is fueling the growth of this segment in the global amblyopia market.
Based on types, the market has been classified as strabismus amblyopia, refractive amblyopia, deprivation amblyopia, reverse amblyopia, and others. The strabismus amblyopia segment holds a key share of the amblyopia market. Moreover, this segment is estimated to expand at a significant CAGR during the forecast period due to increasing number of patients with strabismus amblyopia.
Definitions By Types Deprivation Amblyopia: This is common type of amblyopia, which is developed when the visual axis is obstructed. In some patients this is caused by something that obstructs being focused on a baby's eye. Eyelid ptosis, cataracts, corneal opacities, vitreous hemorrhage and others are various causes of stimulus deprivation.
Refractive Amblyopia: Unequal refractive error in the eyes causes amblyopia. For example, one eye can have substantial uncorrected farsightedness or nearsightedness, while the other eye does not. In such cases the human relies on the eyes with fewer errors, causing amblyopia in that eye from disuse.
Reverse Amblyopia: This kind of amblyopia adversely affects binocularity, contrast sensitivity, grating acuity visual acuity, and central versus eccentric fixation.
Strabismus Amblyopia: Strabismus is a predominant cause of amblyopia. The brain lacks the visual feedback from the misaligned eye to prevent double vision caused by incorrectly aligned eyes, resulting in amblyopia in that eye. This type of amblyopia is called strabismus amblyopia. Strabismus amblyopia results from suppression of the deviating eye. Constant strabismus leads to more severe amblyopia than intermittent strabismus.
Regional Outlook
In terms of regions, the global amblyopia market has been fragmented into Europe, North America, Latin America, Asia Pacific and Middle East & Africa. North America is a promising region for the market. The region constituted 37.6% share of the market in 2019. The market in the region is anticipated to expand at a CAGR of ~3.1% during the forecast period.
Significant market share of North America is attributed to the presence of advanced technologies in the medical industry. Moreover, easy availability of recourses supports the growth of key players and new entrance in the market in this region. Increasing number of amblyopia cases in Europe is driving the growth of the market in the region. High purchasing power among consumers in the region positively influences the growth of the market. The market in Asia Pacific region is expected to grow at a significant rate during the forecast period due to increasing availability of amblyopia treatment technologies in the region. Moreover, increasing penetration of new companies, through mergers and acquisitions, fuels the market in the region.
Key Benefits for Industry Participants & Stakeholders
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the global amblyopia market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
Key players in the market include Amblyotech, Good-Lite Co., Vivid Vision, Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss, HOYA Corporation, Fresnel Prism and Lens, and Hilco Vision.
These companies are considered as key players in global amblyopia market based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.
Key players in the market are principally engaged in acquiring regional players to increase their sales and footprint across the globe. For instance, in 2019, CooperVision, Inc., acquired Blanchard Contact Lenses, Inc., which helped the company to expand its presence in the specialty segment.
In the year 2019, Novartis AG acquired Takeda eye drug for approximately US$ 5.3 Bn, which helped the company to expand its product portfolio.
Companies can withstand competition in the amblyopia market by adopting latest technologies, increasing consumer awareness, and partnerships with hospitals and eye care centers.
Chapter 1 Executive Summary Chapter 2 Assumptions and Acronyms Used Chapter 3 Research Methodology Chapter 4 Amblyopia Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Amblyopia Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Amblyopia Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Amblyopia Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Amblyopia Market Size & Forecast, 2017-2027 4.5.1 Amblyopia Market Size and Y-o-Y Growth 4.5.2 Amblyopia Market Absolute $ Opportunity 4.6 Global Amblyopia Market: Regulatory Outlook Chapter 5 Global Amblyopia Market Analysis and Forecast By Treatment 5.1 Introduction 5.1.1 Key Market Trends & Growth Opportunities By Treatment 5.1.2 Basis Point Share (BPS) Analysis By Treatment 5.1.3 Absolute $ Opportunity Assessment By Treatment 5.2 Amblyopia Market Size Forecast By Treatment 5.2.1 Eye Patches 5.2.2 Glasses 5.2.3 Video Game 5.2.4 Atropine Drops 5.2.5 Others 5.3 Market Attractiveness Analysis By Treatment Chapter 6 Global Amblyopia Market Analysis and Forecast By End-user 6.1 Introduction 6.1.1 Key Market Trends & Growth Opportunities By End-user 6.1.2 Basis Point Share (BPS) Analysis By End-user 6.1.3 Absolute $ Opportunity Assessment By End-user 6.2 Amblyopia Market Size Forecast By End-user 6.2.1 Hospitals & Pharmacies 6.2.2 Ophthalmic Clinics 6.2.3 Others 6.3 Market Attractiveness Analysis By End-user Chapter 7 Global Amblyopia Market Analysis and Forecast By Diagnosis 7.1 Introduction 7.1.1 Key Market Trends & Growth Opportunities By Diagnosis 7.1.2 Basis Point Share (BPS) Analysis By Diagnosis 7.1.3 Absolute $ Opportunity Assessment By Diagnosis 7.2 Amblyopia Market Size Forecast By Diagnosis 7.2.1 Visual Acuity Tests 7.2.2 Photo Screening 7.2.3 Brückner Test 7.2.4 Others 7.3 Market Attractiveness Analysis By Diagnosis Chapter 8 Global Amblyopia Market Analysis and Forecast By Type 8.1 Introduction 8.1.1 Key Market Trends & Growth Opportunities By Type 8.1.2 Basis Point Share (BPS) Analysis By Type 8.1.3 Absolute $ Opportunity Assessment By Type 8.2 Amblyopia Market Size Forecast By Type 8.2.1 Strabismus Amblyopia 8.2.2 Refractive Amblyopia 8.2.3 Deprivation Amblyopia 8.2.4 Reverse Amblyopia 8.2.5 Others 8.3 Market Attractiveness Analysis By Type Chapter 9 Global Amblyopia Market Analysis and Forecast by Region 9.1 Introduction 9.1.1 Key Market Trends & Growth Opportunities by Region 9.1.2 Basis Point Share (BPS) Analysis by Region 9.1.3 Absolute $ Opportunity Assessment by Region 9.2 Amblyopia Market Size Forecast by Region 9.2.1 North America 9.2.2 Europe 9.2.3 Asia Pacific 9.2.4 Latin America 9.2.5 Middle East & Africa (MEA) 9.3 Market Attractiveness Analysis by Region Chapter 10 Coronavirus Disease (COVID-19) Impact 10.1 Introduction 10.2 Current & Future Impact Analysis 10.3 Economic Impact Analysis 10.4 Government Policies 10.5 Investment Scenario Chapter 11 North America Amblyopia Analysis and Forecast 11.1 Introduction 11.2 North America Amblyopia Market Size Forecast by Country 11.2.1 U.S. 11.2.2 Canada 11.3 Basis Point Share (BPS) Analysis by Country 11.4 Absolute $ Opportunity Assessment by Country 11.5 Market Attractiveness Analysis by Country 11.6 North America Amblyopia Market Size Forecast By Treatment 11.6.1 Eye Patches 11.6.2 Glasses 11.6.3 Video Game 11.6.4 Atropine Drops 11.6.5 Others 11.7 Basis Point Share (BPS) Analysis By Treatment 11.8 Absolute $ Opportunity Assessment By Treatment 11.9 Market Attractiveness Analysis By Treatment 11.10 North America Amblyopia Market Size Forecast By End-user 11.10.1 Hospitals & Pharmacies 11.10.2 Ophthalmic Clinics 11.10.3 Others 11.11 Basis Point Share (BPS) Analysis By End-user 11.12 Absolute $ Opportunity Assessment By End-user 11.13 Market Attractiveness Analysis By End-user 11.14 North America Amblyopia Market Size Forecast By Diagnosis 11.14.1 Visual Acuity Tests 11.14.2 Photo Screening 11.14.3 Brückner Test 11.14.4 Others 11.15 Basis Point Share (BPS) Analysis By Diagnosis 11.16 Absolute $ Opportunity Assessment By Diagnosis 11.17 Market Attractiveness Analysis By Diagnosis 11.18 North America Amblyopia Market Size Forecast By Type 11.18.1 Strabismus Amblyopia 11.18.2 Refractive Amblyopia 11.18.3 Deprivation Amblyopia 11.18.4 Reverse Amblyopia 11.18.5 Others 11.19 Basis Point Share (BPS) Analysis By Type 11.20 Absolute $ Opportunity Assessment By Type 11.21 Market Attractiveness Analysis By Type Chapter 12 Europe Amblyopia Analysis and Forecast 12.1 Introduction 12.2 Europe Amblyopia Market Size Forecast by Country 12.2.1 Germany 12.2.2 France 12.2.3 Italy 12.2.4 U.K. 12.2.5 Spain 12.2.6 Russia 12.2.7 Rest of Europe 12.3 Basis Point Share (BPS) Analysis by Country 12.4 Absolute $ Opportunity Assessment by Country 12.5 Market Attractiveness Analysis by Country 12.6 Europe Amblyopia Market Size Forecast By Treatment 12.6.1 Eye Patches 12.6.2 Glasses 12.6.3 Video Game 12.6.4 Atropine Drops 12.6.5 Others 12.7 Basis Point Share (BPS) Analysis By Treatment 12.8 Absolute $ Opportunity Assessment By Treatment 12.9 Market Attractiveness Analysis By Treatment 12.10 Europe Amblyopia Market Size Forecast By End-user 12.10.1 Hospitals & Pharmacies 12.10.2 Ophthalmic Clinics 12.10.3 Others 12.11 Basis Point Share (BPS) Analysis By End-user 12.12 Absolute $ Opportunity Assessment By End-user 12.13 Market Attractiveness Analysis By End-user 12.14 Europe Amblyopia Market Size Forecast By Diagnosis 12.14.1 Visual Acuity Tests 12.14.2 Photo Screening 12.14.3 Brückner Test 12.14.4 Others 12.15 Basis Point Share (BPS) Analysis By Diagnosis 12.16 Absolute $ Opportunity Assessment By Diagnosis 12.17 Market Attractiveness Analysis By Diagnosis 12.18 Europe Amblyopia Market Size Forecast By Type 12.18.1 Strabismus Amblyopia 12.18.2 Refractive Amblyopia 12.18.3 Deprivation Amblyopia 12.18.4 Reverse Amblyopia 12.18.5 Others 12.19 Basis Point Share (BPS) Analysis By Type 12.20 Absolute $ Opportunity Assessment By Type 12.21 Market Attractiveness Analysis By Type Chapter 13 Asia Pacific Amblyopia Analysis and Forecast 13.1 Introduction 13.2 Asia Pacific Amblyopia Market Size Forecast by Country 13.2.1 China 13.2.2 Japan 13.2.3 South Korea 13.2.4 India 13.2.5 Australia 13.2.6 South East Asia (SEA) 13.2.7 Rest of Asia Pacific (APAC) 13.3 Basis Point Share (BPS) Analysis by Country 13.4 Absolute $ Opportunity Assessment by Country 13.5 Market Attractiveness Analysis by Country 13.6 Asia Pacific Amblyopia Market Size Forecast By Treatment 13.6.1 Eye Patches 13.6.2 Glasses 13.6.3 Video Game 13.6.4 Atropine Drops 13.6.5 Others 13.7 Basis Point Share (BPS) Analysis By Treatment 13.8 Absolute $ Opportunity Assessment By Treatment 13.9 Market Attractiveness Analysis By Treatment 13.10 Asia Pacific Amblyopia Market Size Forecast By End-user 13.10.1 Hospitals & Pharmacies 13.10.2 Ophthalmic Clinics 13.10.3 Others 13.11 Basis Point Share (BPS) Analysis By End-user 13.12 Absolute $ Opportunity Assessment By End-user 13.13 Market Attractiveness Analysis By End-user 13.14 Asia Pacific Amblyopia Market Size Forecast By Diagnosis 13.14.1 Visual Acuity Tests 13.14.2 Photo Screening 13.14.3 Brückner Test 13.14.4 Others 13.15 Basis Point Share (BPS) Analysis By Diagnosis 13.16 Absolute $ Opportunity Assessment By Diagnosis 13.17 Market Attractiveness Analysis By Diagnosis 13.18 Asia Pacific Amblyopia Market Size Forecast By Type 13.18.1 Strabismus Amblyopia 13.18.2 Refractive Amblyopia 13.18.3 Deprivation Amblyopia 13.18.4 Reverse Amblyopia 13.18.5 Others 13.19 Basis Point Share (BPS) Analysis By Type 13.20 Absolute $ Opportunity Assessment By Type 13.21 Market Attractiveness Analysis By Type Chapter 14 Latin America Amblyopia Analysis and Forecast 14.1 Introduction 14.2 Latin America Amblyopia Market Size Forecast by Country 14.2.1 Brazil 14.2.2 Mexico 14.2.3 Rest of Latin America (LATAM) 14.3 Basis Point Share (BPS) Analysis by Country 14.4 Absolute $ Opportunity Assessment by Country 14.5 Market Attractiveness Analysis by Country 14.6 Latin America Amblyopia Market Size Forecast By Treatment 14.6.1 Eye Patches 14.6.2 Glasses 14.6.3 Video Game 14.6.4 Atropine Drops 14.6.5 Others 14.7 Basis Point Share (BPS) Analysis By Treatment 14.8 Absolute $ Opportunity Assessment By Treatment 14.9 Market Attractiveness Analysis By Treatment 14.10 Latin America Amblyopia Market Size Forecast By End-user 14.10.1 Hospitals & Pharmacies 14.10.2 Ophthalmic Clinics 14.10.3 Others 14.11 Basis Point Share (BPS) Analysis By End-user 14.12 Absolute $ Opportunity Assessment By End-user 14.13 Market Attractiveness Analysis By End-user 14.14 Latin America Amblyopia Market Size Forecast By Diagnosis 14.14.1 Visual Acuity Tests 14.14.2 Photo Screening 14.14.3 Brückner Test 14.14.4 Others 14.15 Basis Point Share (BPS) Analysis By Diagnosis 14.16 Absolute $ Opportunity Assessment By Diagnosis 14.17 Market Attractiveness Analysis By Diagnosis 14.18 Latin America Amblyopia Market Size Forecast By Type 14.18.1 Strabismus Amblyopia 14.18.2 Refractive Amblyopia 14.18.3 Deprivation Amblyopia 14.18.4 Reverse Amblyopia 14.18.5 Others 14.19 Basis Point Share (BPS) Analysis By Type 14.20 Absolute $ Opportunity Assessment By Type 14.21 Market Attractiveness Analysis By Type Chapter 15 Middle East & Africa (MEA) Amblyopia Analysis and Forecast 15.1 Introduction 15.2 Middle East & Africa (MEA) Amblyopia Market Size Forecast by Country 15.2.1 Saudi Arabia 15.2.2 South Africa 15.2.3 UAE 15.2.4 Rest of Middle East & Africa (MEA) 15.3 Basis Point Share (BPS) Analysis by Country 15.4 Absolute $ Opportunity Assessment by Country 15.5 Market Attractiveness Analysis by Country 15.6 Middle East & Africa (MEA) Amblyopia Market Size Forecast By Treatment 15.6.1 Eye Patches 15.6.2 Glasses 15.6.3 Video Game 15.6.4 Atropine Drops 15.6.5 Others 15.7 Basis Point Share (BPS) Analysis By Treatment 15.8 Absolute $ Opportunity Assessment By Treatment 15.9 Market Attractiveness Analysis By Treatment 15.10 Middle East & Africa (MEA) Amblyopia Market Size Forecast By End-user 15.10.1 Hospitals & Pharmacies 15.10.2 Ophthalmic Clinics 15.10.3 Others 15.11 Basis Point Share (BPS) Analysis By End-user 15.12 Absolute $ Opportunity Assessment By End-user 15.13 Market Attractiveness Analysis By End-user 15.14 Middle East & Africa (MEA) Amblyopia Market Size Forecast By Diagnosis 15.14.1 Visual Acuity Tests 15.14.2 Photo Screening 15.14.3 Brückner Test 15.14.4 Others 15.15 Basis Point Share (BPS) Analysis By Diagnosis 15.16 Absolute $ Opportunity Assessment By Diagnosis 15.17 Market Attractiveness Analysis By Diagnosis 15.18 Middle East & Africa (MEA) Amblyopia Market Size Forecast By Type 15.18.1 Strabismus Amblyopia 15.18.2 Refractive Amblyopia 15.18.3 Deprivation Amblyopia 15.18.4 Reverse Amblyopia 15.18.5 Others 15.19 Basis Point Share (BPS) Analysis By Type 15.20 Absolute $ Opportunity Assessment By Type 15.21 Market Attractiveness Analysis By Type Chapter 16 Competition Landscape 16.1 Amblyopia Market: Competitive Dashboard 16.2 Global Amblyopia Market: Market Share Analysis, 2019 16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 16.3.1 Amblyotech 16.3.2 Novartis AG 16.3.3 Good-Lite Co. 16.3.4 VividVision Inc. 16.3.5 CooperVision Inc. 16.3.6 Johnson & Johnson 16.3.7 Novartis AG 16.3.8 Carl Zeiss AG 16.3.9 HOYA Corporation 16.3.10 Fresnel Prism and Lens Co. 16.3.11 Hilco Vision
Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you. Strategy Head of Major Tech Company
We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality. Major Player in Defense Industry
Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions. CMO of Leading Packaging Company from USA
I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data. Founder and Managing Partner of Major Korean Company
Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports. Global Consulting Firm
According to this Growth Market Reports report, the market from amblyopia is likely to register a CAGR of 4.0% during forecast period between 2020 and 2027, with an anticipated valuation of US$ 6,203.6 million by the end of the 2027.
Market size (in US$ Million) and company market share (in % for base year 2019), other data such as COVID-19 impact on amblyopia market and regulatory outlook is available in the final report.
Changing lifestyles and preferences, health awareness, medical industry advancement, introduction of new treatment methods, and increase in R&D expenditure by manufacturers for developing new amblyopia treatment equipment is expected to drive the market growth during forecast period.
The market is expected to witness decline of over 2.3% between 2019 and due to the adverse impact of COVID 19 pandemic on supply chain of medical industry.
The base year considered for the global amblyopia market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017, 2018 are the historic years, 2019 is the base year and the forecast is provided from 2020 to 2027.
Request For Customization
Enquiry Before Buying
Speak With Analyst
